These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13110848)

  • 1. [Free amino acids in blood and cerebrospinal fluid in Parkinson's disease].
    TORRE M; SCARZELLA R; ZANALDA A
    Minerva Med; 1953 Jul; 44(59-60):256. PubMed ID: 13110848
    [No Abstract]   [Full Text] [Related]  

  • 2. Amino acid abnormalities in cerebrospinal fluid and blood serum of patients with Parkinson's disease, other heredodegenerative disorders and head injuries.
    Lakke JP; Teelken AW; vd Voet H; Wolthers BG
    Adv Neurol; 1987; 45():243-7. PubMed ID: 3825697
    [No Abstract]   [Full Text] [Related]  

  • 3. Ventricular cerebrospinal fluid concentrations of putative amino acid transmitters in Parkinson's disease and other disorders.
    Perschak H; Amsler U; Vischer A; Siegfried J; Cuénod M
    Hum Neurobiol; 1987; 6(3):191-4. PubMed ID: 2896652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid neuraminic acid in parkinsonism and schizophrenia.
    PAPADOPOULOS NM; McLANE JE; O'DOHERTY D; HESS WC
    J Nerv Ment Dis; 1959 May; 128(5):450-2. PubMed ID: 13665366
    [No Abstract]   [Full Text] [Related]  

  • 5. Free amino acids in the cerebrospinal fluid in old age and in Parkinson's disease.
    Gjessing LR; Gjesdahl P; Dietrichson P; Presthus J
    Eur Neurol; 1974; 12(1):33-7. PubMed ID: 4413508
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson's disease.
    Mally J; Szalai G; Stone TW
    J Neurol Sci; 1997 Oct; 151(2):159-62. PubMed ID: 9349670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of amino acids in the cerebrospinal fluid].
    Mashiko N
    Nihon Rinsho; 1973 May; 31(5):1029-37. PubMed ID: 4738411
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of the administration of amino acids, especially of L-dopa and alpha-methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. II. Alterations of cerebrospinal fluid in patients with Parkinson's disease and chorea following the administration of alpha-methyldopa].
    Gründig E; Gerstenbrand F; Bruck J; Gnad H; Prosenz P; Simanyi M
    Dtsch Z Nervenheilkd; 1969; 196(3):256-65. PubMed ID: 5820717
    [No Abstract]   [Full Text] [Related]  

  • 9. Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease.
    Engelborghs S; Marescau B; De Deyn PP
    Neurochem Res; 2003 Aug; 28(8):1145-50. PubMed ID: 12834252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid abnormalities in cerebrospinal fluid of patients with parkinsonism and extrapyramidal disorders.
    Lakke JP; Teelken AW
    Neurology; 1976 May; 26(5):489-93. PubMed ID: 944400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of amino acids in cerebrospinal fluid from patients with Parkinson's disease and spinocerebellar degeneration.
    Araki K; Takino T; Ida S; Kuriyama K
    Acta Neurol Scand; 1986 Feb; 73(2):105-10. PubMed ID: 3705920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid amino acids in extrapyramidal disorders before and after L-DOPA treatment.
    Van Sande M; Caers J; Lowenthal A
    Z Neurol; 1971 Apr; 199(1):24-9. PubMed ID: 4102746
    [No Abstract]   [Full Text] [Related]  

  • 13. Polyunsaturated fatty acid levels in the cerebrospinal fluid of patients with Parkinson's disease and multiple system atrophy.
    Lee PH; Lee G; Paik MJ
    Mov Disord; 2008 Jan; 23(2):309-10. PubMed ID: 18067192
    [No Abstract]   [Full Text] [Related]  

  • 14. [Free amino acids in the cerebrospinal fluid in otogenic intracranial complications].
    FEIGIN GA
    Vopr Med Khim; 1961; 7():291-6. PubMed ID: 13698624
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebrospinal fluid arginine vasopressin in Parkinson's disease, dementia, and other degenerative disorders.
    Olsson JE; Forsling ML; Lindvall B; Akerlund M
    Adv Neurol; 1987; 45():239-42. PubMed ID: 3825696
    [No Abstract]   [Full Text] [Related]  

  • 16. A significant reduction of putative transmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease and spinocerebellar degeneration.
    Tohgi H; Abe T; Hashiguchi K; Takahashi S; Nozaki Y; Kikuchi T
    Neurosci Lett; 1991 May; 126(2):155-8. PubMed ID: 1681472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease.
    Isobe C; Murata T; Sato C; Terayama Y
    Life Sci; 2005 Aug; 77(15):1836-43. PubMed ID: 15935398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the free amino acid pattern in human cerebrospinal fluid along the cerebrospinal axis.
    Szilágyi AK; Lavinha F; Mardens Y
    Acta Neurol Belg; 1974; 74(6):329-36. PubMed ID: 4469117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chromatographic determination of free amino acids in cephalorachidian fluid].
    KEMALI D; PORCELLATI G
    Boll Soc Ital Biol Sper; 1953 Jun; 29(6):1182-4. PubMed ID: 13126277
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevated concentration of cerebrospinal fluid tissue transglutaminase in Parkinson's disease indicating apoptosis.
    Vermes I; Steur EN; Jirikowski GF; Haanen C
    Mov Disord; 2004 Oct; 19(10):1252-4. PubMed ID: 15368613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.